Healthcare experts have raised alarms about hair loss, a condition that is affecting hundreds and thousands of residents in the UAE. According to doctors, ..
/CNW/ - LEO Pharma Inc. announced today the Health Canada approval of Adtralza® (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis (AD).